RSS

Anti-Aging Medicine Needs Risky & Probably Unethical Clinical Experiments

Anti-Aging Medicine Needs Risky & Probably Unethical Clinical Experiments

Related Article: Is Longevity Research Ethical? Yes it Is

Seeking volunteers in good health for participating in clinical experiments of treatments that have been designed to fundamentally increase man’s life span. The treatments that are being experimented can change your brain as well as your body at the levels of your cells.

We might be seeing notices such as this in the near future. In accordance with current media stories, drugs against ageing might soon alter from a mere dream into a scientifically practical prospect. It is noteworthy to address the hazardous results of a prevalent belief that human ageing may be stopped or reversed. For anti-ageing drugs to become a truth, there is a need to test a number of theories, regarding halting or reversing the ageing process, on human beings. Performing these tests will undoubtedly put unparalleled pressure on the regulations defending human members in clinical experiments, which are previously continuously disregarded.

Actually there exist two kinds of anti-ageing research. Firstly there is the conventional approach which focuses on illnesses of ageing such as the Alzheimer’s, cancer, type 2 diabetes, atherosclerosis as well as other life-limiting diseases which develop themselves as we age. Keeping in line with this school of thought, if we are able to conquer them we will have the possibility to grow old more healthily and gracefully – and probably have a more extended life span.

Other than that there is the rather ambitious approach which considers ageing itself as an aliment. Aubrey de Grey, the creator of SENS, Strategies for Engineered Negligible Senescence Foundation, is among the busiest person found in this field. De Grey dreams of a future where human beings turn insignificantly senescent: Man will no more go through progressive decrepitude that ends unavoidably in death. Aubrey de Grey is envisaging therapies which will interfere in the process of ageing in wider and deeper ways compared to any drug known till now that help reduces Alzheimer’s plaques or aids people suffering form diabetes to bring an improvement in the regulation of their blood sugar. Grey concepts regarding Rejuvenation Biotech can be found in Slate.

Many of Aubrey de Grey’s critic have named him a snake oil salesman. However, this is unjust, mostly due to the fact the he is far from being in the trade of oil or anything else which may be bottled. What Aubrey de Grey is doing is selling a concept – the proposal of agelessness as being a practical objective. In case a stop or a considerable delay to ageing is possible – plus there is no cause to believe it is otherwise, even though it is surely going to prove to be a big challenge – then the quicker we begin to seek for it truly, the quickest we are prone to discover it.

In order to give a push to this process, Aubrey de Grey gave a helping hand in creation of the Methuselah Foundation. The latter provides cash rewards to researchers able in surpassing past performance regarding the lifespan of a mouse. The highest performance being 1819 days in January 2012 – quite good for an animal whose lifespan is expected to be of one year when living in the wild. Mice with a curiously extended life span could arouse people to the probability of drastically prolonging the life span of man in nearly the same way as Dolly the sheep stirred hopes along with fears regarding human cloning.

At a point in time, individuals will need to experiment the therapies which have proved to be successful in extending the lifetime of mice. The Methuselah mice can be efficient is evidence of concept; illustrations that the lifetime of the mammal species comprising human beings may be radically extended. However they surely will not demonstrate that any one anti-ageing therapy is without any danger. There exist several biological differentiations between the mouse and an individual; a treatment which is able to bring a mouse to live upto 3000 days may quickly bring an end to the life of a man. It is indeed in the field of experimenting that there exist significant disparities between research related to illnesses of ageing and research on ageing as being a aliment in itself.

It is not much hard to lure those people who are already patients of diseases related to ageing into clinical experiments. For instance, persons suffering from the Alzheimer’s agree that they are suffering from a serious disease. They recognize that several new medicines will not work – that a number of them might even make them feel sicker. They perceive these risks as being guaranteed.

Human being trials of new therapies that treat ageing as being a disease are another issue. The possible advantages might be enormous, however so, also, are the dangers. Moreover, to show that untried therapies may prolong the lifetime of persons unaffected by any considerable illness related to ageing, researchers will require performing experiments on similar persons – this implies, enjoying healthy ageing. Persuading these kinds of people to undergo hazardous treatments will certainly be challenging.

Take Aubrey de Grey’s recommended treatment for cancer; that can be considered as the deal-breaker for those aspiring life extenders. Its occurrence considerably rises as one ages, implying that the people who are able to reach their 150th birthday prior to the discovery of a healing or at the very least a really effective therapy would be recommended to develop an appreciation for chemotherapy.

Aubrey de Grey is known as a fervent advocate of whole-body interdiction of the lengthening of telomeres, also commonly known are WILT. The latter are the protecting sequences of the DNA at the last part of chromosomes. WILT is considered as being a “cure” involving the removal of telomerase gene from each cell in the body. Several cancers gain the ability to grow without restriction through the hijack of this particular gene.

Aubrey de Grey’s treatment for cancer is associated with an important price; the telomerase gene is present for a cause. A great number of parts of man’s body churn all through cells at a quite quick rate. Devoid of a properly functioning telomerase gene, our human body would quickly lack white blood cells, platelets and red blood cells. De Grey recommends frequent sessions of stem cell therapies in order to make provision of the lacking cells. It does not mean that WILT may not function or in case it does work, it could not direct to hypotheses that in fact do.

It is believed that persons who are fascinated by SENS are most likely to be particularly disinclined to the types of dangers that are involved in clinical experiments. They are, in any case, being lured by the assurance of millennial lifetimes. There is no reason for them to put down their name for risky clinical experiments for anti-ageing therapies while there exist other alternatives; like paying someone else to perform their dirty work. Far from several fictional depictions, there will not be one “cure” for ageing, which, once found, can securely be offered to anybody who wishes for it and can pay the price.

Researchers will put in place numerous therapies directed at distinctive kinds of damage that are related to ageing. All of them will require much testing. There will undoubtedly be several fake turns as well as disappointments all through the way. The anti-ageing researchers will have to have a good supply of human tests subjects who are in good health. A broad acknowledgement of the scientific probability of fundamentally prolonging human lifetime will create a sense of exigency. Trials on human beings need to take place as soon as possible for safe anti-ageing therapies to come in time to stop the biological decrepitude ultimately leading to death, that is awaiting the current 40 years old advocates of SENS.

The Presidential Commission for the Study of Bioethical Issues recently published a report calling for more protections for participants in clinical experiments. It searches to obstruct Big Pharm’s past practice to find jurisdictions less fussy regarding the rights of their subjects regarding clinical trials. For example, in the 1940s, American doctors intentionally infected above seven hundred Guatemalans with syphilis. The expectation of a healing for ageing will generate stronger desires compare to the hope of an improved treatment for syphilis. People who are powerful and rich will be seeking ways to do away with regulations which they view as disallowing them an extended lifetime.

Related Article: Is Longevity Research Ethical? Yes it Is

Source: Slate

, , ,

, , , , , , ,

Comments are closed.